miR-196b promotes NSCLC progression and metastasis by targeting the tumor suppressors, TSPAN12, GATA6, and FAS (Liang et al., 2020) (Huang et al., 2020). This evidence concerns the gene GATA6 and non-small cell lung carcinoma.